{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Metabolic Enzyme & Protease > DalcetrapibCAS：211513-37-0
Molecular Formula：C23H35NO2S
Molecular Weight：389.59
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 211513-37-0 |
| Name | Dalcetrapib |
| Molecular Formula | C23H35NO2S |
| Molecular Weight | 389.59 |
| Solubility | Soluble in DMSO ≥5mg/mL;Soluble in Water ＜ 1mg/mL |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| MDL | MFCD06407886 |
| SMILES | CC(C)C(SC1=C(NC(C2(CC(CC)CC)CCCCC2)=O)C=CC=C1)=O |
| Target Point | CETP |
| Passage | Metabolic Enzyme&Protease |
| Background | Dalcetrapib is an rhCETP inhibitor that increases plasma HDL cholesterol. |
| Biological Activity | 是一种rhCETP抑制剂，IC50为0.2 μM，提高血浆中高密度脂蛋白（HDL）胆固醇。[1] |
| IC50 | rhCETP: 0.2μM [1] |
| Data Literature Source | [1] Niesor EJ，et al. J Lipid Res. 2010，51(12)，3443-3454. [2] Shinkai H，et al. J Med Chem. 2000，43(19)，3566-3572. [3] Huang Z，et al. Am J Physiol Endocrinol Metab. 2003，284(6)，E1210-E1219. [4] Zhang B，et al. Arterioscler Thromb Vasc Biol. 2004，24(10)，1910-1915. |
| Unit | Bottle |
| Specification | 5mg 10mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
